TreeWAS – Variant ID: rs1747683

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T39.0 Salicylates	0.065	0.935	0.000
K51.4 Pseudopolyposis of colon	0.057	0.943	0.000
J93.9 Pneumothorax, unspecified	0.052	0.948	0.000
K51 Ulcerative colitis	0.045	0.955	0.000
K51.8 Other ulcerative colitis	0.040	0.960	0.000
K51.2 Ulcerative (chronic) proctitis	0.040	0.960	0.000
K51.0 Ulcerative (chronic) enterocolitis	0.037	0.963	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.036	0.964	0.000
K51.1 Ulcerative (chronic) ileocolitis	0.035	0.965	0.000
K51.3 Ulcerative (chronic) rectosigmoiditis	0.033	0.967	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.029	0.971	0.000
K51.5 Mucosal proctocolitis	0.027	0.973	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.026	0.974	0.000
T39.4 Antirheumatics, not elsewhere classified	0.026	0.974	0.000
T39.2 Pyrazolone derivatives	0.026	0.974	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.023	0.977	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.023	0.977	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.022	0.978	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.021	0.979	0.000
T39.1 4-Aminophenol derivatives	0.020	0.980	0.000
T46.1 Calcium-channel blockers	0.020	0.980	0.000
K51.9 Ulcerative colitis, unspecified	0.019	0.981	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.019	0.981	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.019	0.981	0.000
T43.6 Psychostimulants with abuse potential	0.019	0.981	0.000
J93 Pneumothorax	0.019	0.981	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.018	0.982	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.018	0.982	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.018	0.982	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.017	0.983	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.017	0.983	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.016	0.984	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.016	0.984	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.016	0.984	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.016	0.984	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.016	0.984	0.000
T50.8 Diagnostic agents	0.016	0.984	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.016	0.984	0.000
T50.1 Loop [high-ceiling] diuretics	0.016	0.984	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.016	0.984	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.016	0.984	0.000
T46.7 Peripheral vasodilators	0.016	0.984	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.016	0.984	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.015	0.985	0.000
T50.7 Analeptics and opioid receptor antagonists	0.015	0.985	0.000
T50.5 Appetite depressants	0.015	0.985	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.015	0.985	0.000
T50.0 Mineralocorticoids and their antagonists	0.015	0.985	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.015	0.985	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.015	0.985	0.000
T43.2 Other and unspecified antidepressants	0.015	0.985	0.000
T36 Poisoning by systemic antibiotics	0.015	0.985	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.015	0.985	0.000
T50.4 Drugs affecting uric acid metabolism	0.015	0.985	0.000
T43.9 Psychotropic drug, unspecified	0.015	0.985	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.015	0.985	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.014	0.986	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.014	0.986	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.014	0.986	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.014	0.986	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.014	0.986	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.013	0.986	0.000
J93.0 Spontaneous tension pneumothorax	0.013	0.987	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.013	0.987	0.000
T49.9 Topical agent, unspecified	0.013	0.987	0.000
T49.8 Other topical agents	0.013	0.987	0.000
T49.7 Dental drugs, topically applied	0.013	0.987	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.013	0.987	0.000
T49.5 Ophthalmological drugs and preparations	0.013	0.987	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.013	0.987	0.000
T49.3 Emollients, demulcents and protectants	0.013	0.987	0.000
T49.2 Local astringents and local detergents	0.013	0.987	0.000
T49.1 Antipruritics	0.013	0.987	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.013	0.987	0.000
T37.5 Antiviral drugs	0.013	0.987	0.000
T37.4 Anthelminthics	0.013	0.987	0.000
T37.3 Other antiprotozoal drugs	0.013	0.987	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.013	0.987	0.000
T37.1 Antimycobacterial drugs	0.013	0.987	0.000
T37.0 Sulphonamides	0.013	0.987	0.000
J93.1 Other spontaneous pneumothorax	0.013	0.987	0.000
T48.5 Anti-common-cold drugs	0.012	0.987	0.000
T47.4 Other laxatives	0.012	0.988	0.000
T41.5 Therapeutic gases	0.012	0.988	0.000
T41.4 Anaesthetic, unspecified	0.012	0.988	0.000
T41.3 Local anaesthetics	0.012	0.988	0.000
T41.2 Other and unspecified general anaesthetics	0.012	0.988	0.000
T41.1 Intravenous anaesthetics	0.012	0.988	0.000
T41.0 Inhaled anaesthetics	0.012	0.988	0.000
T45.2 Vitamins, not elsewhere classified	0.012	0.988	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.012	0.988	0.000
T47.2 Stimulant laxatives	0.012	0.988	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.012	0.988	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.012	0.988	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.012	0.988	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.012	0.988	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.012	0.988	0.000
T44.0 Anticholinesterase agents	0.012	0.988	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.012	0.988	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.012	0.988	0.000
T47.7 Emetics	0.012	0.988	0.000
T47.5 Digestants	0.012	0.988	0.000
T47.3 Saline and osmotic laxatives	0.012	0.988	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.011	0.988	0.000
T48.4 Expectorants	0.011	0.988	0.000
T48.3 Antitussives	0.011	0.988	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.011	0.988	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.011	0.988	0.000
T48.0 Oxytocic drugs	0.011	0.988	0.000
T36.8 Other systemic antibiotics	0.012	0.988	0.000
J93.8 Other pneumothorax	0.012	0.988	0.000
T47.0 Histamine H(2)-receptor antagonists	0.011	0.988	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.011	0.988	0.000
T47.6 Antidiarrhoeal drugs	0.011	0.989	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.011	0.989	0.000
T38.1 Thyroid hormones and substitutes	0.011	0.989	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.011	0.989	0.000
T36.9 Systemic antibiotic, unspecified	0.011	0.989	0.000
T36.7 Antifungal antibiotics, systemically used	0.011	0.989	0.000
T36.6 Rifamycins	0.011	0.989	0.000
T36.5 Aminoglycosides	0.011	0.989	0.000
T36.4 Tetracyclines	0.011	0.989	0.000
T36.2 Chloramphenicol group	0.011	0.989	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.011	0.989	0.000
T38.9 Other and unspecified hormone antagonists	0.011	0.989	0.000
T38.7 Androgens and anabolic congeners	0.011	0.989	0.000
T38.5 Other oestrogens and progestogens	0.011	0.989	0.000
T38.4 Oral contraceptives	0.011	0.989	0.000
T38.2 Antithyroid drugs	0.011	0.989	0.000
T38.0 Glucocorticoids and synthetic analogues	0.011	0.989	0.000
T40.5 Cocaine	0.011	0.989	0.000
J38.7 Other diseases of larynx	0.000	0.989	0.011
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.010	0.989	0.000
T36.3 Macrolides	0.010	0.989	0.000
T40.2 Other opioids	0.011	0.989	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.010	0.990	0.000
T45.8 Other primarily systemic and haematological agents	0.010	0.990	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.010	0.990	0.000
T45.6 Fibrinolysis-affecting drugs	0.010	0.990	0.000
T45.4 Iron and its compounds	0.010	0.990	0.000
T45.3 Enzymes, not elsewhere classified	0.010	0.990	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.010	0.990	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.010	0.990	0.000
T40.8 Lysergide [LSD]	0.010	0.990	0.000
T40.7 Cannabis (derivatives)	0.010	0.990	0.000
T40.3 Methadone	0.010	0.990	0.000
T40.1 Heroin	0.010	0.990	0.000
T40.0 Opium	0.010	0.990	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.010	0.990	0.000
T45.0 Antiallergic and antiemetic drugs	0.010	0.990	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.009	0.990	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.009	0.990	0.000
J38.3 Other diseases of vocal cords	0.000	0.991	0.009
K46.9 Unspecified abdominal hernia without obstruction or gangrene	0.000	0.991	0.009
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.009	0.991	0.000
T36.0 Penicillins	0.008	0.992	0.000
T82.8 Other complications of cardiac and vascular prosthetic devices, implants and grafts	0.000	0.992	0.008
J38 Diseases of vocal cords and larynx, not elsewhere classified	0.000	0.992	0.008
T40.4 Other synthetic narcotics	0.007	0.992	0.000
F41.1 Generalised anxiety disorder	0.007	0.993	0.000
M43.16 Spondylolisthesis (Lumbar region)	0.000	0.993	0.007
T40.6 Other and unspecified narcotics	0.006	0.993	0.000
M79.86 Other specified soft tissue disorders (Lower leg)	0.007	0.993	0.000
T45.5 Anticoagulants	0.006	0.993	0.000
J38.5 Laryngeal spasm	0.000	0.993	0.007
F25.9 Schizoaffective disorder, unspecified	0.000	0.993	0.007
T43.0 Tricyclic and tetracyclic antidepressants	0.006	0.993	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.006	0.994	0.000
Z13.6 Special screening examination for cardiovascular disorders	0.006	0.994	0.000
Z54.0 Convalescence following surgery	0.000	0.994	0.006
J38.6 Stenosis of larynx	0.000	0.994	0.006
G82.5 Tetraplegia, unspecified	0.006	0.994	0.000
J38.0 Paralysis of vocal cords and larynx	0.000	0.994	0.006
N28.1 Cyst of kidney, acquired	0.005	0.995	0.000
K46 Unspecified abdominal hernia	0.000	0.995	0.005
I31.3 Pericardial effusion (noninflammatory)	0.000	0.995	0.005
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.005	0.995	0.000
J38.4 Oedema of larynx	0.000	0.995	0.005
T42.5 Mixed antiepileptics, not elsewhere classified	0.005	0.995	0.000
T42.3 Barbiturates	0.005	0.995	0.000
T42.2 Succinimides and oxazolidinediones	0.005	0.995	0.000
G82 Paraplegia and tetraplegia	0.005	0.995	0.000
K46.0 Unspecified abdominal hernia with obstruction, without gangrene	0.000	0.995	0.005
T82.5 Mechanical complication of other cardiac and vascular devices and implants	0.000	0.995	0.005
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.005	0.995	0.000
T82 Complications of cardiac and vascular prosthetic devices, implants and grafts	0.000	0.995	0.005
G82.1 Spastic paraplegia	0.005	0.995	0.000
T84.1 Mechanical complication of internal fixation device of bones of limb	0.000	0.995	0.005
T82.0 Mechanical complication of heart valve prosthesis	0.000	0.996	0.004
T42.4 Benzodiazepines	0.004	0.996	0.000
T42.1 Iminostilbenes	0.004	0.996	0.000
G82.0 Flaccid paraplegia	0.004	0.996	0.000
J38.2 Nodules of vocal cords	0.000	0.996	0.004
T82.4 Mechanical complication of vascular dialysis catheter	0.000	0.996	0.004
K46.1 Unspecified abdominal hernia with gangrene	0.000	0.996	0.004
T42.0 Hydantoin derivatives	0.004	0.996	0.000
F25 Schizoaffective disorders	0.000	0.996	0.004
T82.3 Mechanical complication of other vascular grafts	0.000	0.996	0.004
G82.4 Spastic tetraplegia	0.004	0.996	0.000
G82.3 Flaccid tetraplegia	0.004	0.996	0.000
T82.1 Mechanical complication of cardiac electronic device	0.000	0.996	0.004
J38.1 Polyp of vocal cord and larynx	0.000	0.996	0.004
T85.7 Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts	0.000	0.996	0.004
G80 Infantile cerebral palsy	0.004	0.996	0.000
F25.1 Schizoaffective disorder, depressive type	0.000	0.996	0.003
I36.1 Nonrheumatic tricuspid (valve) insufficiency	0.000	0.996	0.003
G80.8 Other infantile cerebral palsy	0.003	0.997	0.000
M47.99 Spondylosis, unspecified (Site unspecified)	0.000	0.997	0.003
F25.0 Schizoaffective disorder, manic type	0.000	0.997	0.003
D52.9 Folate deficiency anaemia, unspecified	0.000	0.997	0.003
G80-G83 Cerebral palsy and other paralytic syndromes	0.003	0.997	0.000
G83 Other paralytic syndromes	0.003	0.997	0.000
J90-J94 Other diseases of pleura	0.003	0.997	0.000
G83.9 Paralytic syndrome, unspecified	0.003	0.997	0.000
F25.8 Other schizoaffective disorders	0.000	0.997	0.003
F25.2 Schizoaffective disorder, mixed type	0.000	0.997	0.003
L43.9 Lichen planus, unspecified	0.003	0.997	0.000
H61.2 Impacted cerumen	0.000	0.997	0.003
T82.6 Infection and inflammatory reaction due to cardiac valve prosthesis	0.000	0.997	0.003
G80.9 Infantile cerebral palsy, unspecified	0.003	0.997	0.000
G80.1 Spastic diplegia	0.003	0.997	0.000
G80.0 Spastic cerebral palsy	0.003	0.997	0.000
T93.9 Sequelae of unspecified injury of lower limb	0.000	0.997	0.003
G83.8 Other specified paralytic syndromes	0.003	0.997	0.000
G82.2 Paraplegia, unspecified	0.003	0.997	0.000
J91 Pleural effusion in conditions classified elsewhere	0.003	0.997	0.000
K50-K52 Noninfective enteritis and colitis	0.003	0.997	0.000
G80.4 Ataxic cerebral palsy	0.003	0.997	0.000
G80.3 Dyskinetic cerebral palsy	0.003	0.997	0.000
X62.9 Unspecified place	0.003	0.997	0.000
G47.0 Disorders of initiating and maintaining sleep [insomnias]	0.000	0.997	0.003
L40.0 Psoriasis vulgaris	0.003	0.997	0.000
T82.7 Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts	0.000	0.997	0.003
T93.3 Sequelae of dislocation, sprain and strain of lower limb	0.000	0.997	0.003
G83.4 Cauda equina syndrome	0.003	0.997	0.000
N28.0 Ischaemia and infarction of kidney	0.003	0.997	0.000
N28 Other disorders of kidney and ureter, not elsewhere classified	0.003	0.997	0.000
G80.2 Infantile hemiplegia	0.002	0.997	0.000
M25.77 Osteophyte (Ankle and foot)	0.003	0.997	0.000
G83.5 Locked-in syndrome	0.002	0.997	0.000
G83.3 Monoplegia, unspecified	0.002	0.997	0.000
G83.0 Diplegia of upper limbs	0.002	0.997	0.000
T93.0 Sequelae of open wound of lower limb	0.000	0.997	0.003
M24.15 Other articular cartilage disorders (Pelvic region and thigh)	0.003	0.997	0.000
N64.8 Other specified disorders of breast	0.000	0.997	0.003
T93 Sequelae of injuries of lower limb	0.000	0.997	0.003
S92.00 Fracture of calcaneus (closed)	0.003	0.997	0.000
T82.9 Unspecified complication of cardiac and vascular prosthetic device, implant and graft	0.000	0.997	0.002
J20.9 Acute bronchitis, unspecified	0.003	0.997	0.000
T85.6 Mechanical complication of other specified internal prosthetic devices, implants and grafts	0.000	0.997	0.003
J90 Pleural effusion, not elsewhere classified	0.003	0.997	0.000
M22.8 Other disorders of patella	0.000	0.998	0.002
T82.2 Mechanical complication of coronary artery bypass and valve grafts	0.000	0.998	0.002
N18.4 Chronic kidney disease, stage 4	0.000	0.998	0.002
T93.5 Sequelae of injury of muscle and tendon of lower limb	0.000	0.998	0.002
Z54 Convalescence	0.000	0.998	0.002
G83.2 Monoplegia of upper limb	0.002	0.998	0.000
Z91.5 Personal history of self-harm	0.002	0.998	0.000
F80.1 Expressive language disorder	0.002	0.998	0.000
R49.8 Other and unspecified voice disturbances	0.000	0.998	0.002
F60.3 Emotionally unstable personality disorder	0.002	0.998	0.000
G51.3 Clonic hemifacial spasm	0.000	0.998	0.002
K76.9 Liver disease, unspecified	0.000	0.998	0.002
O99.0 Anaemia complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
C26.0 Intestinal tract, part unspecified	0.002	0.998	0.000
K57.2 Diverticular disease of large intestine with perforation and abscess	0.000	0.998	0.002
T93.6 Sequelae of crushing injury and traumatic amputation of lower limb	0.000	0.998	0.002
T93.4 Sequelae of injury of nerve of lower limb	0.000	0.998	0.002
G83.1 Monoplegia of lower limb	0.002	0.998	0.000
O62.2 Other uterine inertia	0.002	0.998	0.000
B95.4 Other streptococcus as the cause of diseases classified to other chapters	0.000	0.998	0.002
T93.2 Sequelae of other fractures of lower limb	0.000	0.998	0.002
Q24.8 Other specified congenital malformations of heart	0.002	0.998	0.000
G58.9 Mononeuropathy, unspecified	0.000	0.998	0.002
M22.3 Other derangements of patella	0.000	0.998	0.002
J86.9 Pyothorax without fistula	0.002	0.998	0.000
M22.9 Disorder of patella, unspecified	0.000	0.998	0.002
M22.2 Patellofemoral disorders	0.000	0.998	0.002
Z54.7 Convalescence following combined treatment	0.000	0.998	0.002
Z54.3 Convalescence following psychotherapy	0.000	0.998	0.002
Z54.2 Convalescence following chemotherapy	0.000	0.998	0.002
Z54.1 Convalescence following radiotherapy	0.000	0.998	0.002
H92.0 Otalgia	0.000	0.998	0.002
Z54.9 Convalescence following unspecified treatment	0.000	0.998	0.002
Z54.8 Convalescence following other treatment	0.000	0.998	0.002
J20.8 Acute bronchitis due to other specified organisms	0.002	0.998	0.000
Z86.5 Personal history of other mental and behavioural disorders	0.002	0.998	0.000
N28.9 Disorder of kidney and ureter, unspecified	0.002	0.998	0.000
L43 Lichen planus	0.002	0.998	0.000
M47.26 Other spondylosis with radiculopathy (Lumbar region)	0.000	0.998	0.002
L73.2 Hidradenitis suppurativa	0.000	0.998	0.002
N08.3 Glomerular disorders in diabetes mellitus	0.002	0.998	0.000
M13.97 Arthritis, unspecified (Ankle and foot)	0.000	0.998	0.002
M84.17 Nonunion of fracture [pseudarthrosis] (Ankle and foot)	0.002	0.998	0.000
B02.9 Zoster without complication	0.002	0.998	0.000
H66.1 Chronic tubotympanic suppurative otitis media	0.002	0.998	0.000
Z54.4 Convalescence following treatment of fracture	0.000	0.998	0.002
M24.11 Other articular cartilage disorders (Shoulder region)	0.002	0.998	0.000
B02.3 Zoster ocular disease	0.002	0.998	0.000
F12.1 Harmful use	0.002	0.998	0.000
M43.1 Spondylolisthesis	0.000	0.998	0.002
S68.1 Traumatic amputation of other single finger (complete)(partial)	0.000	0.998	0.002
J20 Acute bronchitis	0.002	0.998	0.000
M22 Disorders of patella	0.000	0.998	0.002
T93.8 Sequelae of other specified injuries of lower limb	0.000	0.998	0.002
N08.5 Glomerular disorders in systemic connective tissue disorders	0.002	0.998	0.000
U88 Agent resistant to multiple antibiotics	0.002	0.998	0.000
M24.02 Loose body in joint (Upper arm)	0.002	0.998	0.000
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs	0.000	0.998	0.002
S92.0 Fracture of calcaneus	0.002	0.998	0.000
M48.00 Spinal stenosis (Multiple sites in spine)	0.002	0.998	0.000
T85.9 Unspecified complication of internal prosthetic device, implant and graft	0.000	0.998	0.002
C80.0 Malignant neoplasm, primary site unknown, so stated	0.002	0.998	0.000
L43.0 Hypertrophic lichen planus	0.002	0.998	0.000
L43.3 Subacute (active) lichen planus	0.002	0.998	0.000
L43.2 Lichenoid drug reaction	0.002	0.998	0.000
L43.1 Bullous lichen planus	0.002	0.998	0.000
I31 Other diseases of pericardium	0.000	0.998	0.002
S92.01 Fracture of calcaneus (open)	0.002	0.998	0.000
M43.19 Spondylolisthesis (Site unspecified)	0.000	0.998	0.002
M43.18 Spondylolisthesis (Sacral and sacrococcygeal region)	0.000	0.998	0.001
M43.15 Spondylolisthesis (Thoracolumbar region)	0.000	0.998	0.001
M43.13 Spondylolisthesis (Cervicothoracic region)	0.000	0.998	0.001
M43.11 Spondylolisthesis (Occipito-atlanto-axial region)	0.000	0.998	0.001
M43.10 Spondylolisthesis (Multiple sites in spine)	0.000	0.998	0.001
B02.8 Zoster with other complications	0.002	0.998	0.000
G62.8 Other specified polyneuropathies	0.000	0.998	0.002
H00.0 Hordeolum and other deep inflammation of eyelid	0.002	0.998	0.000
J20.7 Acute bronchitis due to echovirus	0.001	0.998	0.000
J20.6 Acute bronchitis due to rhinovirus	0.001	0.998	0.000
J20.5 Acute bronchitis due to respiratory syncytial virus	0.001	0.998	0.000
J20.4 Acute bronchitis due to parainfluenza virus	0.001	0.998	0.000
J20.3 Acute bronchitis due to coxsackie virus	0.001	0.998	0.000
J20.2 Acute bronchitis due to streptococcus	0.001	0.998	0.000
J20.1 Acute bronchitis due to Haemophilus influenzae	0.001	0.998	0.000
J20.0 Acute bronchitis due to Mycoplasma pneumoniae	0.001	0.998	0.000
M22.1 Recurrent subluxation of patella	0.000	0.998	0.001
M51.8 Other specified intervertebral disk disorders	0.002	0.998	0.000
H61.9 Disorder of external ear, unspecified	0.000	0.998	0.002
Z90.6 Acquired absence of other parts of urinary tract	0.000	0.998	0.002
D52 Folate deficiency anaemia	0.000	0.998	0.002
M22.0 Recurrent dislocation of patella	0.000	0.998	0.001
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.001	0.998	0.000
H61 Other disorders of external ear	0.000	0.998	0.002
N08 Glomerular disorders in diseases classified elsewhere	0.002	0.998	0.000
E27.8 Other specified disorders of adrenal gland	0.002	0.998	0.000
S89.9 Unspecified injury of lower leg	0.000	0.998	0.002
I36 Nonrheumatic tricuspid valve disorders	0.000	0.998	0.002
M19.07 Primary arthrosis of other joints (Ankle and foot)	0.000	0.998	0.002
M62.89 Other specified disorders of muscle (Site unspecified)	0.002	0.998	0.000
I45.6 Preexcitation syndrome	0.000	0.998	0.002
K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene	0.002	0.998	0.000
T93.1 Sequelae of fracture of femur	0.000	0.998	0.001
Y83.4 Other reconstructive surgery	0.000	0.998	0.002
B02 Zoster [herpes zoster]	0.002	0.998	0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.001	0.998	0.000
N04.9 Unspecified	0.001	0.998	0.000
M77.02 Medial epicondylitis (Upper arm)	0.000	0.998	0.001
D48.1 Connective and other soft tissue	0.001	0.998	0.000
I31.1 Chronic constrictive pericarditis	0.000	0.999	0.001
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.001	0.999	0.000
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.000	0.999	0.001
M43.14 Spondylolisthesis (Thoracic region)	0.000	0.999	0.001
M43.12 Spondylolisthesis (Cervical region)	0.000	0.999	0.001
H61.3 Acquired stenosis of external ear canal	0.000	0.999	0.001
I31.8 Other specified diseases of pericardium	0.000	0.999	0.001
I31.2 Haemopericardium, not elsewhere classified	0.000	0.999	0.001
Y79.2 Prosthetic and other implants, materials and accessory devices	0.001	0.999	0.000
G81 Hemiplegia	0.001	0.999	0.000
B02.1 Zoster meningitis	0.001	0.999	0.000
N04.2 Diffuse membranous glomerulonephritis	0.001	0.999	0.000
M22.10 Recurrent subluxation of patella, unspecified knee	0.000	0.999	0.001
F11.2 Dependence syndrome	0.001	0.999	0.000
I31.0 Chronic adhesive pericarditis	0.000	0.999	0.001
I87.8 Other specified disorders of veins	0.001	0.999	0.000
J86.0 Pyothorax with fistula	0.001	0.999	0.000
K42.0 Umbilical hernia with obstruction, without gangrene	0.001	0.999	0.000
Z94.0 Kidney transplant status	0.001	0.999	0.000
E78.2 Mixed hyperlipidaemia	0.001	0.999	0.000
S51.8 Open wound of other parts of forearm	0.000	0.999	0.001
Z13.2 Special screening examination for nutritional disorders	0.001	0.999	0.000
M62.11 Other rupture of muscle (nontraumatic) (Shoulder region)	0.001	0.999	0.000
C09.9 Tonsil, unspecified	0.001	0.999	0.000
D52.8 Other folate deficiency anaemias	0.000	0.999	0.001
D52.1 Drug-induced folate deficiency anaemia	0.000	0.999	0.001
D52.0 Dietary folate deficiency anaemia	0.000	0.999	0.001
J86 Pyothorax	0.001	0.999	0.000
M24.17 Other articular cartilage disorders (Ankle and foot)	0.001	0.999	0.000
L02.9 Cutaneous abscess, furuncle and carbuncle, unspecified	0.001	0.999	0.000
M24.1 Other articular cartilage disorders	0.001	0.999	0.000
N08.8 Glomerular disorders in other diseases classified elsewhere	0.001	0.999	0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.001	0.999	0.000
N08.1 Glomerular disorders in neoplastic diseases	0.001	0.999	0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.001	0.999	0.000
M19.27 Other secondary arthrosis (Ankle and foot)	0.000	0.999	0.001
M24.05 Loose body in joint (Pelvic region and thigh)	0.001	0.999	0.000
B02.7 Disseminated zoster	0.001	0.999	0.000
B02.0 Zoster encephalitis	0.001	0.999	0.000
I36.9 Nonrheumatic tricuspid valve disorder, unspecified	0.000	0.999	0.001
I36.8 Other nonrheumatic tricuspid valve disorders	0.000	0.999	0.001
I36.2 Nonrheumatic tricuspid (valve) stenosis with insufficiency	0.000	0.999	0.001
I36.0 Nonrheumatic tricuspid (valve) stenosis	0.000	0.999	0.001
L40.4 Guttate psoriasis	0.001	0.999	0.000
L43.8 Other lichen planus	0.001	0.999	0.000
X62.0 Home	0.001	0.999	0.000
X62.7 Farm	0.001	0.999	0.000
X62.6 Industrial and construction area	0.001	0.999	0.000
X62.5 Trade and service area	0.001	0.999	0.000
X62.4 Street and highway	0.001	0.999	0.000
X62.3 Sports and athletics area	0.001	0.999	0.000
X62.2 School, other institution and public administrative area	0.001	0.999	0.000
X62.1 Residential institution	0.001	0.999	0.000
Z13.1 Special screening examination for diabetes mellitus	0.001	0.999	0.000
F11.1 Harmful use	0.001	0.999	0.000
H54.7 Unspecified visual loss	0.001	0.999	0.000
X62.8 Other specified place	0.001	0.999	0.000
Z13.7 Special screening examination for congenital malformations, deformations and chromosomal abnormalities	0.001	0.999	0.000
M24.14 Other articular cartilage disorders (Hand)	0.001	0.999	0.000
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.001	0.999	0.000
J94 Other pleural conditions	0.001	0.999	0.000
S12.20 Fracture of other specified cervical vertebra (closed)	0.000	0.999	0.001
S92.20 Fracture of other tarsal bone(s) (closed)	0.001	0.999	0.000
G81.0 Flaccid hemiplegia	0.001	0.999	0.000
L89.2 Stage III decubitus ulcer	0.001	0.999	0.000
Y79.3 Surgical instruments, materials and devices (including sutures)	0.001	0.999	0.000
Z44.3 Fitting and adjustment of external breast prosthesis	0.001	0.999	0.000
L42 Pityriasis rosea	0.001	0.999	0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.999	0.001
C08.9 Major salivary gland, unspecified	0.001	0.999	0.000
O61.0 Failed medical induction of labour	0.000	0.999	0.001
L40 Psoriasis	0.001	0.999	0.000
M84.11 Nonunion of fracture [pseudarthrosis] (Shoulder region)	0.001	0.999	0.000
L40.1 Generalised pustular psoriasis	0.001	0.999	0.000
L40-L45 Papulosquamous disorders	0.001	0.999	0.000
J94.2 Haemothorax	0.000	0.999	0.001
L02.2 Cutaneous abscess, furuncle and carbuncle of trunk	0.001	0.999	0.000
S46.2 Injury of muscle and tendon of other parts of biceps	0.000	0.999	0.001
F80 Specific developmental disorders of speech and language	0.001	0.999	0.000
M24.19 Other articular cartilage disorders (Site unspecified)	0.001	0.999	0.000
M24.18 Other articular cartilage disorders (Other)	0.001	0.999	0.000
M24.12 Other articular cartilage disorders (Upper arm)	0.001	0.999	0.000
M24.10 Other articular cartilage disorders (Multiple sites)	0.001	0.999	0.000
M24.47 Recurrent dislocation and subluxation of joint (Ankle and foot)	0.000	0.999	0.001
X62.09 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified: Home: During unspecified activity	0.001	0.999	0.000
D26.1 Corpus uteri	0.000	0.999	0.001
N30.2 Other chronic cystitis	0.001	0.999	0.000
S92.41 Fracture of great toe (open)	0.001	0.999	0.000
J94.0 Chylous effusion	0.001	0.999	0.000
K10.2 Inflammatory conditions of jaws	0.000	0.999	0.001
N04 Nephrotic syndrome	0.001	0.999	0.000
O85 Puerperal sepsis	0.000	0.999	0.001
J94.9 Pleural condition, unspecified	0.001	0.999	0.000
K76.6 Portal hypertension	0.000	0.999	0.001
L40.2 Acrodermatitis continua	0.001	0.999	0.000
Z13 Special screening examination for other diseases and disorders	0.001	0.999	0.000
D04.4 Skin of scalp and neck	0.001	0.999	0.000
D35.0 Adrenal gland	0.001	0.999	0.000
D63.8 Anaemia in other chronic diseases classified elsewhere	0.001	0.999	0.000
F80.9 Developmental disorder of speech and language, unspecified	0.001	0.999	0.000
F80.8 Other developmental disorders of speech and language	0.001	0.999	0.000
F80.3 Acquired aphasia with epilepsy [Landau-Kleffner]	0.001	0.999	0.000
F80.0 Specific speech articulation disorder	0.001	0.999	0.000
L73.9 Follicular disorder, unspecified	0.001	0.999	0.000
N04.0 Minor glomerular abnormality	0.001	0.999	0.000
L41 Parapsoriasis	0.001	0.999	0.000
L45 Papulosquamous disorders in diseases classified elsewhere	0.001	0.999	0.000
L44 Other papulosquamous disorders	0.001	0.999	0.000
U89 Agent resistant to other and unspecified antibiotics	0.001	0.999	0.000
M62.15 Other rupture of muscle (nontraumatic) (Pelvic region and thigh)	0.001	0.999	0.000
M84.16 Nonunion of fracture [pseudarthrosis] (Lower leg)	0.001	0.999	0.000
G57.8 Other mononeuropathies of lower limb	0.001	0.999	0.000
I49.9 Cardiac arrhythmia, unspecified	0.000	0.999	0.001
M24.0 Loose body in joint	0.001	0.999	0.000
M62.1 Other rupture of muscle (nontraumatic)	0.001	0.999	0.000
N04.8 Other	0.001	0.999	0.000
N04.7 Diffuse crescentic glomerulonephritis	0.001	0.999	0.000
N04.6 Dense deposit disease	0.001	0.999	0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.001	0.999	0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.001	0.999	0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.001	0.999	0.000
U89.9 Agent resistant to unspecified antibiotic	0.001	0.999	0.000
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.001	0.999	0.000
F12.5 Psychotic disorder	0.001	0.999	0.000
G81.1 Spastic hemiplegia	0.001	0.999	0.000
H61.8 Other specified disorders of external ear	0.000	0.999	0.001
H61.0 Perichondritis of external ear	0.000	0.999	0.001
U89.8 Agent resistant to other single specified antibiotic	0.001	0.999	0.000
T68 Hypothermia	0.001	0.999	0.000
T85 Complications of other internal prosthetic devices, implants and grafts	0.000	0.999	0.001
Y79 Orthopaedic devices associated with adverse incidents	0.001	0.999	0.000
I67.1 Cerebral aneurysm, nonruptured	0.000	0.999	0.001
L41.9 Parapsoriasis, unspecified	0.001	0.999	0.000
L41.8 Other parapsoriasis	0.001	0.999	0.000
L41.5 Retiform parapsoriasis	0.001	0.999	0.000
L41.4 Large plaque parapsoriasis	0.001	0.999	0.000
L41.3 Small plaque parapsoriasis	0.001	0.999	0.000
L41.2 Lymphomatoid papulosis	0.001	0.999	0.000
L41.1 Pityriasis lichenoides chronica	0.001	0.999	0.000
L41.0 Pityriasis lichenoides et varioliformis acuta	0.001	0.999	0.000
S92.2 Fracture of other tarsal bone(s)	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations